Adjustment disorder with mixed anxiety and depressed mood
Methodology & AI Transparency ⓘ
Adjustment disorder with mixed anxiety and depressed mood Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Clinical triage of Adjustment disorder with mixed anxiety and depressed mood (F43.23) in Anxiety & PTSD relies on cognitive-behavioral exposure readiness in Adjustment disorder with mixed anxiety and depressed mood (F43.23: evaluation), guiding step-wise therapeutic adjustments toward GAD-7 Anxiety Severity in Adjustment disorder with mixed anxiety and depressed mood (F43.23: Score) (< 4 (minimal anxiety) (F43.23)).
- 2 Real-world patient consensus: Clinical coding for Adjustment disorder with mixed anxiety and depressed mood uses ICD-10 F43.23 across Anxiety & PTSD specialty care.
- 3 Typical cash cost range: Differential triage of Adjustment disorder with mixed anxiety and depressed mood (F43.23) utilizes cognitive-behavioral exposure readiness in Adjustment disorder with mixed anxiety and depressed mood (F43.23: evaluation).
- 4 Top reported side effects / signs: Objective lab/clinical target for Adjustment disorder with mixed anxiety and depressed mood: TSH & Ferritin in Adjustment disorder with mixed anxiety and depressed mood (F43.23: Rule-Out) (TSH 0.8–2.5 mIU/L; Ferritin > 50 ng/mL (F43.23)) and GAD-7 Anxiety Severity in Adjustment disorder with mixed anxiety and depressed mood (F43.23: Score).
Ask our AI Specialists anything about Adjustment disorder with mixed anxiety and depressed mood
What Is Adjustment disorder with mixed anxiety and depressed mood?
Clinical triage of Adjustment disorder with mixed anxiety and depressed mood (F43.23) in Anxiety & PTSD relies on cognitive-behavioral exposure readiness in Adjustment disorder with mixed anxiety and depressed mood (F43.23: evaluation), guiding step-wise therapeutic adjustments toward GAD-7 Anxiety Severity in Adjustment disorder with mixed anxiety and depressed mood (F43.23: Score) (< 4 (minimal anxiety) (F43.23)).
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Adjustment disorder with mixed anxiety and depressed mood (ICD-10 F43.23) is driven by autonomic vagal withdrawal [Adjustment disorder with mixed anxiety and depressed mood F43.23]; specialists in Anxiety, OCD & Trauma Disorders monitor GAD-7 Anxiety Severity in Adjustment disorder with mixed anxiety and depressed mood (F43.23: Score) to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Presentation of Adjustment disorder with mixed anxiety and depressed mood (F43.23): avoidance of triggers, in Adjustment disorder with mixed anxiety and depressed mood (F43.23: intrusive trauma memories,)
- • Secondary Adjustment disorder with mixed anxiety and depressed mood clinical sign: excessive, hard-to-control anticipatory in Adjustment disorder with mixed anxiety and depressed mood (F43.23: worry or intrusive)
- • Symptom flares in Adjustment disorder with mixed anxiety and depressed mood correlating with TSH & Ferritin in Adjustment disorder with mixed anxiety and depressed mood (F43.23: Rule-Out) deviation outside TSH 0.8–2.5 mIU/L; Ferritin > 50 ng/mL (F43.23)
- • Functional anxiety & ptsd impact requiring cognitive-behavioral exposure readiness in Adjustment disorder with mixed anxiety and depressed mood (F43.23: evaluation) evaluation (F43.23)
Adjustment disorder with mixed anxiety and depressed mood Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | F43.23 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Anxiety, OCD & Trauma Disorders | NLM Clinical Tables |
| Diagnostic / Lab Marker: TSH & Ferritin in Adjustment disorder with mixed anxiety and depressed mood (F43.23: Rule-Out) | TSH 0.8–2.5 mIU/L; Ferritin > 50 ng/mL (F43.23) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: GAD-7 Anxiety Severity in Adjustment disorder with mixed anxiety and depressed mood (F43.23: Score) | < 4 (minimal anxiety) (F43.23) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Resting Heart Rate in Adjustment disorder with mixed anxiety and depressed mood (F43.23: Variability (HRV)) | Stable upward personal trend (F43.23) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Adjustment disorder with mixed anxiety and depressed mood
Treatment selection for Adjustment disorder with mixed anxiety and depressed mood depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Adjustment disorder with mixed anxiety and depressed mood)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Anxiety, repetitive and restricted behaviors and interests, and social: What a 322-Participant Study Found However, a mediation analysis revealed that the effect of CSCI on anxiety was fully explained by RRB (P = 0.17). Scientific reports • 2025-11-06 • Phase III Randomized Trial | N = 322 | 87/100 | PMID 41198718 ↗ |
| New Insights on Digital Cognitive Behavioral Treatment for Generalized anxiety: A Randomized: What a 351-Participant Study Found A total of 351 adults were randomized (175 DCBT, 176 psychoeducation; mean [SD] age, 40.6 [10.9] years; 259 [73.8%] women). JAMA network open • 2025-12-01 • Randomized Controlled Trial | N = 351 | 87/100 | PMID 41396602 ↗ |
| What the Latest Evidence Really Says About Effectiveness and safety of repetitive transcranial magnetic stimulation for The rTMS could be an effective and safe treatment for patients with GAD. General hospital psychiatry • 2025-01-15 • Meta-Analysis | Multi-cohort | 86/100 | PMID 40974751 ↗ |
Adjustment disorder with mixed anxiety and depressed mood Patient Community & “People Like Me” Threads
Filter Adjustment disorder with mixed anxiety and depressed mood community threads and patient logs by age, biological sex, dosage, and treatment duration.